Next Post

Teva meets profit expectations but misses on revenue

&#13 Teva Pharmaceutical Industries Ltd. (NYSE: TEVA TASE: TEVA) nowadays documented $3.7 billion profits for the initially quarter of 2022, down 8% from the corresponding quarter of 2021, and a little under the analysts’ consensus of $3.75 billion. Non-GAAP earnings for each share was $.55, assembly the analysts’ forecast. &#13 […]

You May Like

Next Post

Teva meets profit expectations but misses on revenue

&#13 Teva Pharmaceutical Industries Ltd. (NYSE: TEVA TASE: TEVA) nowadays documented $3.7 billion profits for the initially quarter of 2022, down 8% from the corresponding quarter of 2021, and a little under the analysts’ consensus of $3.75 billion. Non-GAAP earnings for each share was $.55, assembly the analysts’ forecast. &#13 […]

You May Like

oldmoondeliandpie.com WordPress Theme: Seek by ThemeInWP